Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetershill Regulatory News (PHLL)

  • This share is currently suspended. It was suspended at a price of 310.50
  • There is currently no data for PHLL

Total Voting Rights

1 Sep 2023 07:01

RNS Number : 0252L
Petershill Partners PLC
01 September 2023
 

1st September 2023

 

 

PETERSHILL PARTNERS PLC

(the "Company")

 

TOTAL VOTING RIGHTS

 

 

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, as at 31st August 2023, the Company had 1,129,871,832 Ordinary Shares in issue, each with equal voting rights. No shares are held in treasury. Therefore, the total number of voting rights in the Company is 1,129,871,832.

 

Shareholders should use 1,129,871,832 as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

-ENDS-

Ocorian Administration (UK) Limited (Company Secretary)

Theresa Beard +44 777 5658 193

gsam@ocorian.com

Analyst / Investor enquiries:

Gurjit Kambo + 44 (0) 207 051 2564

Gurjit.Kambo@gs.com

 

Media enquiries:

Brunswick Group Advisory Limited PHLL@brunswickgroup.com

Simone Selzer + 44 (0) 207 404 5959

sselzer@brunswickgroup.com

Issued by Petershill Partners Plc

LEI: 213800HTCF8A7XM22A32

Registered in England and Wales No. 13289144

Registered office: 5th Floor, 20 Fenchurch Street, London, England, EC3M 3BY

 

ABOUT PETERSHILL PARTNERS plc.

Petershill Partners plc (the "Company" or "Petershill Partners") and its Subsidiaries (the "Group") is a diversified, global alternatives investment group focused on private equity and other private capital strategies. Through our economic interests in 25 alternative asset management firms ("Partner-firms"), we provide investors with exposure to the growth and profitability of the alternative asset management industry. The Company completed its initial acquisition of the portfolio of Partner-firms on 28 September 2021 and was admitted to listing and trading on the London Stock Exchange on 1 October 2021 (ticker: PHLL). The Company is operated by Goldman Sachs Asset Management ("Goldman Sachs" or the "Operator") and is governed by a diverse and fully independent Board of Directors (the "Board").

 

Through our Partner-firms, we have exposure to $300 billion of total assets under management ("AuM"), comprising a diverse set of more than 200 long-term private equity and other private capital funds where capital is typically locked in over a multi-year horizon. These underlying funds generate recurring management fees and the opportunity for meaningful profit participation over the typical 8+ year lifecycles of such funds. We believe our approach is aligned with the founders and managers of our Partner-firms and, as a result, allows the Company to participate in these income streams in a way that provides high-margin, diversified and stable cash flows for our shareholders.

 

For more information, visit https://www.petershillpartners.com. Information on the website is not incorporated by reference into this press release and is provided merely for convenience.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBRGDIXGXDGXB
Date   Source Headline
23rd May 20252:48 pmRNSDirector/PDMR Shareholding
22nd May 20252:56 pmRNSResults of AGM
22nd May 20257:00 amRNSQ1 Trading Update
17th Apr 20257:00 amRNSNotice of AGM and Proposed Final Dividend
9th Apr 20257:00 amRNS2024 Annual Report and Accounts
31st Mar 20257:00 amRNSPreliminary Results
17th Jan 20257:00 amRNSQ4 2024 AUM Update
16th Jan 20257:00 amRNSSale of majority stake in General Catalyst
20th Nov 20243:40 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSQ3 2024 Trading Update
14th Nov 20247:00 amRNSPartial Sale of Accel-KKR & Special Dividend
17th Sep 20247:00 amRNSInterim Results Statement
4th Sep 20247:00 amRNSSale of stake in LMR Partners
26th Jul 20247:00 amRNSQ2 2024 AUM Update
1st Jul 20247:00 amRNSTotal Voting Rights
19th Jun 20249:55 amRNSDirector/PDMR Shareholding
12th Jun 20246:24 pmRNSHolding(s) in Company
12th Jun 20246:19 pmRNSReplacement: Holding(s) in Company
5th Jun 20247:00 amRNSResults of Tender Offer
23rd May 20243:22 pmRNSResult of AGM
23rd May 20247:00 amRNSQ1 Trading Update
1st May 20247:00 amRNSTotal Voting Rights
23rd Apr 20247:00 amRNSNotice of AGM and Proposed Final Dividend
23rd Apr 20247:00 amRNSProposed Tender Offer
15th Apr 20247:00 amRNSPrivate Funds Shareholding in the Company
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:01 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNS2023 Annual Report and Accounts
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:01 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.